| 英文名称 |
中文名称 |
CAS号 |
操作 |
| GNE-493 |
GNE-493 |
1033735-94-2 |
详细
|
| T-00127_HEV1 |
化合物 T16967 |
900874-91-1 |
详细
|
| PI-828 |
8-(4-氨基苯基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 |
942289-87-4 |
详细
|
| Parsaclisib |
化合物PARSACLISIB |
1426698-88-5 |
详细
|
| BX-912 |
BX-912 |
702674-56-4 |
详细
|
| (Z)-Guggulsterone |
孕二烯二酮 |
39025-23-5 |
详细
|
| TDZD-8 |
4-苯甲基-2-甲基-1,2,4-噻二唑烷-3,5-二酮 |
327036-89-5 |
详细
|
| Metformin D6 hydrochloride |
二甲双胍盐酸 |
1185166-01-1 |
详细
|
| GNE-477 |
GNE 477 |
1032754-81-6 |
详细
|
| Pilaralisib analogue |
XL147 |
956958-53-5 |
详细
|
| BIP-135 |
3-(5-BroMo-1-Methyl-1H-indol-3-yl)-4-(benzofuran-3-yl)pyrrole-2,5-dione |
941575-71-9 |
详细
|
| MK8722 |
MK-8722 |
1394371-71-1 |
详细
|
| RapaLink-1 |
RapaLink-1 |
1887095-82-0 |
详细
|
| EHT 5372 |
CS-2911 |
1425945-60-3 |
详细
|
| PI3K/mTOR Inhibitor-2 |
PI3K/mTOR 抑制剂-2 |
1848242-58-9 |
详细
|
| IPI-3063 |
化合物IPI-3063 |
1425043-73-7 |
详细
|
| 5-Iodo-indirubin-3'-monoxime |
5-IODO-INDIRUBIN-3'-MONOXIME |
331467-03-9 |
详细
|
| Chitosan oligosaccharide |
壳聚糖低聚乳酸酯 |
148411-57-8 |
详细
|
| UCT943 |
UCT943 |
1450666-80-4 |
详细
|
| AZD3458 |
AZD-3458 |
2132961-46-5 |
详细
|
| UCB9608 |
(S)-4-(6-氨基-1-甲基-1H-吡唑并[3,4-D]嘧啶-4-基)-N-(4-甲氧基-2-甲基苯基)-3-甲基哌嗪-1-甲酰胺 |
1616413-96-7 |
详细
|
| IITZ-01 |
IITZ-01 |
1807988-47-1 |
详细
|
| mTOR inhibitor-1 |
152-53-4 |
468747-17-3 |
详细
|
| 9-ING-41 |
9-ING-41 |
1034895-42-5 |
详细
|
| HDACs/mTOR Inhibitor 1 |
HDACS/MTOR INHIBITOR 1 |
2271413-06-8 |
详细
|
| P110δ-IN-1 |
ME401 |
1595129-71-7 |
详细
|
| EB-3D |
EB-3D |
1839150-63-8 |
详细
|
| BRD0705 |
BRD0705 |
2056261-41-5 |
详细
|
| Hematein |
氧化苏木精 |
475-25-2 |
详细
|
| WYE-354 |
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 |
1062169-56-5 |
详细
|
| GSK1059615 |
(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 |
958852-01-2 |
详细
|
| Rigosertib sodium |
瑞格色替钠 |
592542-60-4 |
详细
|
| Rigosertib |
瑞格色替 |
592542-59-1 |
详细
|
| KU-60019 |
KU 60019 |
925701-46-8 |
详细
|
| PHT-427 |
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 |
1191951-57-1 |
详细
|
| CGS 15943 |
CGS 15943 |
104615-18-1 |
详细
|
| IPI549 |
IPI-549 |
1693758-51-8 |
详细
|
| AS-605240 |
5-(6-喹喔啉亚甲基)-2,4-噻唑啉二酮 |
648450-29-7 |
详细
|
| IC-87114 |
2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 |
371242-69-2 |
详细
|
| TG100-115 |
3,3'-(2,4-二氨基-6,7-蝶啶二基)二苯酚 |
677297-51-7 |
详细
|
| TGX-221 |
(+/-)-7-甲基-2-(吗啉-4-基)-9-(1-苯基氨基乙基)吡啶并[1,2-A]嘧啶-4-酮 |
663619-89-4 |
详细
|
| PI-103 |
PI-103 |
371935-74-9 |
详细
|
| PI-103 Hydrochloride |
PI-103 (Hydrochloride) |
371935-79-4 |
详细
|
| GDC-0326 |
GDC0326 |
1282514-88-8 |
详细
|
| GDC-0077 |
GDC-0077 |
2060571-02-8 |
详细
|
| Recilisib |
RECILISIB 钠盐 |
334969-03-8 |
详细
|
| CHIR-99021 monohydrochloride |
CHIR-99021盐酸盐 |
1797989-42-4 |
详细
|
| CHIR-99021 trihydrochloride |
1782235-14-6 |
1782235-14-6 |
详细
|
| PI-273 |
PI-273 |
925069-34-7 |
详细
|
| KDU731 |
KDU731 |
1610610-48-4 |
详细
|
| K00546 |
Cdk1/2 Inhibitor III |
443798-47-8 |
详细
|
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 |
936890-98-1 |
详细
|
| A-443654 |
(ALPHAS)-ALPHA-[[[5-(3-甲基-1H-吲唑-5-基)-3-吡啶基]氧基]甲基]-(S)-1H-吲哚-3-乙胺 |
552325-16-3 |
详细
|
| OSU-03012 |
2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺 |
742112-33-0 |
详细
|
| TWS119 |
TWS119 |
601514-19-6 |
详细
|
| PKI-402 |
PKI-402 |
1173204-81-3 |
详细
|
| PF-AKT400 |
(S)-N-[[3-氨基-1-(5-乙基-7H-吡咯并[2,3-D]嘧啶-4-基)吡咯烷-3-基]甲基]-2,4-二氟苯甲酰胺 |
1004990-28-6 |
详细
|
| PQR530 |
PQR530 |
1927857-61-1 |
详细
|
| A 1070722 |
1-(7-Methoxyquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea |
1384424-80-9 |
详细
|
| PI3Kδ-IN-2 |
YY-20394 |
1702816-75-8 |
详细
|
| AKT Kinase Inhibitor |
AKT 激酶抑制剂 |
842148-40-7 |
详细
|
| Omipalisib |
GSK2126458 |
1086062-66-9 |
详细
|
| PIK-294 |
PIK-294 |
900185-02-6 |
详细
|
| AZD 6482 |
2-[[(1R)-1-[7-甲基-2-(4-吗啉)-4-氧代-4H-吡啶并[1,2-A]嘧啶-9-基]乙基]氨基]苯甲酸 |
1173900-33-8 |
详细
|
| JR-AB2-011 |
JR-AB2-011 |
2411853-34-2 |
详细
|
| STL127705 |
化合物STL127705 |
1326852-06-5 |
详细
|
| Umbralisib hydrochloride |
1532533-78-0 |
1532533-78-0 |
详细
|
| Serabelisib |
[6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮 |
1268454-23-4 |
详细
|
| Borussertib |
Borussertib |
1800070-77-2 |
详细
|
| IM-12 |
IM-12 |
1129669-05-1 |
详细
|
| AZD8186 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 |
1627494-13-6 |
详细
|
| ON 146040 |
1404231-34-0 |
1404231-34-0 |
详细
|
| ETP-46321 |
CS-2500 |
1252594-99-2 |
详细
|
| JNJ-47117096 hydrochloride |
1610536-69-0 |
1610536-69-0 |
详细
|
| (R)-BRD3731 |
|
2056262-08-7 |
详细
|
| BRD3731 |
5H-Pyrazolo[3,4-b]quinolin-5-one, 3-(2,2-dimethylpropyl)-1,2,4,6,7,8-hexahydro-4,7,7-trimethyl-4-phenyl-, (4S)- |
2056262-07-6 |
详细
|
| Vps34-IN-2 |
(S)-1-(3-methyl-2-oxobutyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one |
1523404-29-6 |
详细
|
| Rheb inhibitor NR1 |
化合物 T16741 |
2216763-38-9 |
详细
|
| Samotolisib |
LY-3023414 |
1386874-06-1 |
详细
|
| GSK-3β inhibitor 1 |
2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- |
187325-53-7 |
详细
|
| Acalisib |
GS-9820 |
870281-34-8 |
详细
|
| GNE-317 |
GNE-317 |
1394076-92-6 |
详细
|
| Vps34-IN-1 |
VPS34-IN1 |
1383716-33-3 |
详细
|
| Ampkinone |
CS-2123 |
1233082-79-5 |
详细
|
| Bimiralisib |
PI3K/MTOR抑制剂 |
1225037-39-7 |
详细
|
| AZD-8835 |
AZD-8835 |
1620576-64-8 |
详细
|
| AMG319 |
AMG319 |
1608125-21-8 |
详细
|
| GNF4877 |
GNF4877 |
2041073-22-5 |
详细
|
| Torin 2 |
9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮 |
1223001-51-1 |
详细
|
| Idelalisib |
艾代拉里斯 |
870281-82-6 |
详细
|
| VO-Ohpic trihydrate |
VO-OHPIC 三水合物 |
476310-60-8 |
详细
|
| GSK-3β inhibitor 2 |
GSK-3 β inhibitor 2 |
1702428-31-6 |
详细
|
| KY19382 |
KY19382 |
2226664-93-1 |
详细
|
| CCT128930 |
CCT128930 |
885499-61-6 |
详细
|
| A66 |
A66 |
1166227-08-2 |
详细
|
| BGT226 maleate |
NVP-BGT226 |
1245537-68-1 |
详细
|
| AICAR phosphate |
5-氨基-1-核糖基咪唑-4-甲酰胺磷酸盐 |
681006-28-0 |
详细
|
| Deguelin |
魚藤素 |
522-17-8 |
详细
|
| AMG 511 |
(R)-4-(2-((5-氟-6-甲氧基吡啶-3-基)氨基)-5-(1-(4-(甲基磺酰基)哌嗪-1-基)乙基)吡啶-3-基)-6-甲基-1,3,5-三嗪-2-胺 |
1253573-53-3 |
详细
|
| TG 100713 |
TG 100713,3-(2,4-DIAMINO-6-PTERIDINYL)-PHENOL |
925705-73-3 |
详细
|